கார் டி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from கார் டி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In கார் டி Today - Breaking & Trending Today
Jun 3, 2021 8:40am The setback has led to the winding down of the CART-PSMA-TGFβRDN study. (Image by Dimitris Vetsikas from Pixabay) Tmunity Therapeutics has stopped development of its lead CAR-T therapy after two patients died of a form of neurotoxicity. The news, details of which were first reported by Endpoints, has implications for the broader push to establish cell therapies as treatments for solid tumors. Founded by Carl June, M.D., and Oz Azam, M.D., Tmunity is at the forefront of the push to expand use of CAR-T beyond hematological malignancies and into solid tumors. The University of Pennsylvania, which spawned Tmunity, took dual PSMA-specific, TGFβ-resistant CAR modified autologous T cells into an 18-subject phase 1 prostate cancer trial in 2017. Tmunity began a second, larger study late in 2019. ....